SI Group to Take Albemarle Antioxidant Business

In a deal set to close later this year, Schenectady, New York-based SI Group, a leading producer of phenolic resins, alkylphenolic resins and akylkated phenols, plans to acquire the antioxidant, ibuprofen and propofol activities of U.S. specialty chemicals producer Albemarle. No purchase price has been announced.

Along with manufacturing sites at Orangeburg, South Carolina, and Shanghai, China, the buy includes technical support services in Baton Rouge, Louisiana.

According to Albemarle, the businesses to be divested employ 500 people had sales of around $240 million in 2013, with low-single-digit segment margins.

The ibuprofen and propofol activities belong to Albemarle's fine chemistry service businesses with annual sales of $290 million.

For the SI Group, which employs 2,200 people, the deal is its biggest ever.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.